Phase III trial completed by Bharat Biotech for Nasal Vaccine

Phase III trial completed by Bharat Biotech for Nasal Vaccine

The clinical phase III trials of the Covid-19 nasal vaccination have been finished, according to Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, who stated the company will submit its data to the Drugs Controller General of India (DCGI) next month. Ella remarked, “We recently concluded a clinical experiment and are currently analysing…

Tech Transfer Necessary to Scale Up Vaccine Production: Bharat Biotech Joint MD

Tech Transfer Necessary to Scale Up Vaccine Production: Bharat Biotech Joint MD

In order to scale up production of Covid-19 vaccines, scaling up¬†partnerships, technology transfers and supply of various critical equipment and materials is necessary to cater to the huge demand for vaccines said Bharat Biotech Joint MD Suchitra Ella on Saturday. Ella, speaking at the EU-India Business Roundtable said that more emphasis should be on fostering…